Invesco Biotechnology & Genome ETF (PBE) — ETF Analysis on Winston

Key Facts

• Issuer: Invesco
• Category: Equity
• Asset Class: Equity
• Price: $90.78
• Expense Ratio: 58.00%
• Assets Under Management: $286M
• Number of Holdings: 31
• Inception Date: 2005-06-23
• Currency: USD

Winston Score

Invesco Biotechnology & Genome ETF has a Winston Score of 61 out of 100.

Performance

• 1-Year Return: 29.70%
• 3-Year Return: 29.47%
• 5-Year Return: 2.61%

Top Holdings

Vertex Pharmaceuticals Inc (N/A%), Amgen Inc (N/A%), Royalty Pharma PLC (N/A%), Biogen Inc (N/A%), Alnylam Pharmaceuticals Inc (N/A%)

Sector Breakdown

Healthcare (N/A%)